FamiCord AG (ETR:V3V)
5.60
-0.05 (-0.88%)
At close: Jan 23, 2026
FamiCord AG Revenue
FamiCord AG had revenue of 22.79M EUR in the quarter ending September 30, 2025, with 2.51% growth. This brings the company's revenue in the last twelve months to 88.29M, up 9.48% year-over-year. In the year 2024, FamiCord AG had annual revenue of 82.18M with 6.65% growth.
Revenue (ttm)
88.29M
Revenue Growth
+9.48%
P/S Ratio
1.11
Revenue / Employee
114.51K
Employees
771
Market Cap
97.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82.18M | 5.12M | 6.65% |
| Dec 31, 2023 | 77.06M | 8.12M | 11.78% |
| Dec 31, 2022 | 68.94M | 40.52M | 142.58% |
| Dec 31, 2021 | 28.42M | 8.75M | 44.49% |
| Dec 31, 2020 | 19.67M | -266.00K | -1.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| MEDICLIN Aktiengesellschaft | 793.91M |
| DocCheck AG | 56.12M |
| LIMES Schlosskliniken AG | 41.87M |
| MeVis Medical Solutions AG | 16.64M |
FamiCord AG News
- 10 months ago - FamiCord AG Surpasses 2024 Earnings with Vita 34 Boost, Early Figures Show - Wallstreet:Online
- 1 year ago - Vita 34 Boosts Revenue, Profitability & Cash Flow in Q3 2024 - Wallstreet:Online
- 1 year ago - EQS-News: Vita 34 continues to show increasing revenue, improved profitability and stronger cash generation in the third quarter of 2024 - Wallstreet:Online
- 1 year ago - Vita 34 Boosts Operating Cash Flow in H1 2024, Continues Positive Trend - Wallstreet:Online
- 1 year ago - EQS-News: Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow - Wallstreet:Online
- 1 year ago - EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor - Wallstreet:Online